These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169 [TBL] [Abstract][Full Text] [Related]
5. [Expression of Tcf-4, MMP7 and Survivin in Colorectal Cancer and Its Clinical Significance]. Ou YR; Jing GY; Wu Q; Gao S; Cheng ZN; Dong Xiu-qin Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 46(4):554-9. PubMed ID: 26480657 [TBL] [Abstract][Full Text] [Related]
6. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714 [TBL] [Abstract][Full Text] [Related]
7. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients. Myung SJ; Yang SK; Chang HS; Byeon JS; Kim KJ; Hong SS; Jeong JY; Lee SM; Hong WS; Kim JH; Min YI J Gastroenterol Hepatol; 2005 Oct; 20(10):1578-83. PubMed ID: 16174077 [TBL] [Abstract][Full Text] [Related]
11. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609 [TBL] [Abstract][Full Text] [Related]
12. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth. Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462 [TBL] [Abstract][Full Text] [Related]
14. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618 [TBL] [Abstract][Full Text] [Related]
15. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer. Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750 [TBL] [Abstract][Full Text] [Related]
16. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission. Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374 [TBL] [Abstract][Full Text] [Related]
18. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer. Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342 [TBL] [Abstract][Full Text] [Related]
19. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163 [TBL] [Abstract][Full Text] [Related]
20. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer. Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]